Monthly Archives: February 2015

Weekly Roundup 2.27.15

Another round of snow this week, perhaps the last gasp of winter? I can’t say there is any hint of Spring in the air in these parts, but sure hope there is where you are. In any event, I am … Continue reading

Posted in Weekly Roundup | Comments Off on Weekly Roundup 2.27.15

Legislative Proposals in the 114th Congress

Every so often, EyeonFDA has an update for you on legislation that is proposed in the Congress that would impact the medical product marketplace if passed.  The new Congress has just two months old and while the last Congress was … Continue reading

Posted in Legislation | Comments Off on Legislative Proposals in the 114th Congress

Weekly Roundup 2.20.15

Friiiiiiggggggiiiiiiiddddd.  I realize anyone who doesn’t live in the Northeast can’t really complain, but winter finally woke up in the capital of our nation. Last week I took a picture of green daffodil sprouts coming up from the grounds of … Continue reading

Posted in Weekly Roundup | Comments Off on Weekly Roundup 2.20.15

The Language of Risk – FDA’s Evolution of Thought

How does the average patient assess the risk of a medical product when deciding whether or not to seek it out? This month, FDA released a new draft guidance document entitled “Brief Summary and Adequate Directions for Use: Disclosing Risk … Continue reading

Posted in FDA Policy | Comments Off on The Language of Risk – FDA’s Evolution of Thought

Weekly Roundup 2.13.15

Happy Friday the 13th and the day before Valentine’s Day. It is cold.  There is fierce wind. Boston is due more snow. As if there aren’t enough reasons to dislike February…. For me the week flew by and I hope … Continue reading

Posted in Weekly Roundup | Comments Off on Weekly Roundup 2.13.15